Although current systems for continuous glucose monitoring (CGM) are the result of progressive technological improvement, and although a beneficial effect on glucose control has been demonstrated, few patients are using them. Something similar has happened to telemedicine (TM); in spite of the long-term experience, which began in the early 1980s, no TM system has been widely adopted, and presential visits are still almost the only way diabetologists and patients communicate. The hypothesis developed in this article is that neither CGM nor TM will ever be routinely implemented separately, and their consideration as essential elements for standard diabetes care will one day come from their integration as parts of a telemedical monitoring platform. This platform, which should include artificial intelligence for giving decision support to patients and physicians, will represent the core of a more complex global agent for diabetes care, which will provide control algorithms and risk analysis among other essential functions.
AlbisserAM. Technophobia, prescription checking and the future of diabetes management. Diabetologia.2009; 52 (6): 1013–8.
2.
DeissDBolinderJRivelineJPBattelinoTBosiETubiana-RufiNKerrDPhillipM. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care.2006; 29 (12): 2730–2.
3.
HirschIBAbelsethJBodeBWFischerJSKaufmanFRMastrototaroJParkinCGWolpertHABuckinghamBA. Sensor-augmented insulin pump therapy: Results of the first randomized treat-to-target study. Diabetes Technol Ther.2008; 10 (5): 377–83.
4.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med.;2008; 359 (14): 1464–76.
5.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Buckingham B, Miller K, Wolpert H, Xing D, Block JM, Chase HP, Hirsch I, Kollman C, Laffel L, Lawrence JM, Milaszewski K, Ruedy KJ, Tamborlane WV. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care.;2009; 32 (11): 1947–53.
6.
RiglaMHernandoMEGómezEJBruguésEGarcía-SáezGCapelIPonsBde LeivaA. Real-time continuous glucose monitoring together with telemedical assistance improves glycemic control and glucose stability in pump-treated patients. Diabetes Technol Ther.2008; 10 (3): 194–9.
7.
ChaseHPKimLMOwenSLMacKenzieTAKlingensmithGJMurtfeldtRGargSK. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics.2001; 107 (2): 222–6.
8.
MazzeRSStrockEBorgmanSWesleyDStoutPRacchiniJ. Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): Is CGM ready for real time?Diabetes Technol Ther.2009; 11 (1): 11–8.
9.
FarmerAGibsonOJTarassenkoLNeilA. A systematic review of telemedicine interventions to support blood glucose self-monitoring in diabetes. Diabet Med.2005; 22 (10): 1372–8.
10.
VerhoevenFVan Gemert-PijnenLDijkstraKNijlandNSeydelESteehouderM. The contribution of teleconsultation and videoconferencing to diabetes care: A systematic literature review. J Med Internet Res.2007; 9 (5): e37.
11.
Gómez-AguileraEJdel PozoFSerranoRM. DIACRONO: A new portable microcomputer system for diabetes management. In: Proc. 9th Ann. Int. IEEE Engineering in Medicine and Biology Society; Nov. 13–16, 1987, Vol. 3 of 4, pp. 1231–2.
12.
GómezEJdel PozoFHernandoME. Telemedicine for diabetes care: The DIABTel approach towards diabetes telecare. Med Inform (Lond).1996; 21 (4): 283–95.
13.
BellazziRLarizzaCMontaniSRivaAStefanelliMd'AnnunzioGLoriniRGomezEJHernandoEBruguesECermenoJCorcoyRde LeivaACobelliCNucciGDel PratoSMaranAKilkkiETuominenJ. A telemedicine support for diabetes management: The T-IDDM project. Comput Methods Programs Biomed.2002; 69 (2): 147–61.
14.
SchrezenmeirJDirtingKPapazovP. Controlled multicenter study on the effect of computer assistance in intensive insulin therapy of type 1 diabetics. Comput Methods Programs Biomed.2002; 69 (2): 97–114.
15.
SheaSWeinstockRSTeresiJAPalmasWStarrenJCiminoJJLaiAMFieldLMorinPCGolandRIzquierdoREEbnerSSilverSPetkovaEKongJEimickeJP, IDEATel Consortium. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus: 5 year results of the IDEATel study. J Am Med Inform Assoc.2009; 16 (4): 446–56.
16.
GómezEJPérezME HernandoVeringTCrosM RiglaBottOGarcía-SáezGPretschnerPBruguésESchnellOPatteCBergmannJDuddeRde LeivaA. The INCA System: A further step towards a telemedical artificial pancreas. IEEE Trans Inf Technol Biomed.2008; 12 (4): 470–9.
17.
HovorkaRAllenJMElleriDChassinLJHarrisJXingDKollmanCHovorkaTLarsenAFNodaleMDe PalmaAWilinskaMEAceriniCLDungerDB. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: A phase 2 randomised crossover trial. Lancet.2010; 375 (9716): 743–51.
18.
KlonoffDCTrueMW. The missing element of telemedicine for diabetes: Decision support software. J Diabetes Sci Technol.2009; 3 (5): 996–1001.
19.
SalzsiederEAlbrechtGFischerUFreyseEJ. Kinetic modeling of the glucoregulatory system to improve insulin therapy. IEEE Trans Biomed Eng.1985; 32 (10): 846–55.
20.
HernandoMEGómezEJCorcoyRdel PozoF. Evaluation of DIABNET, a decision support system for therapy planning in gestational diabetes. Comput Methods Programs Biomed.2000; 62 (3): 235–48.
21.
PalermCCZisserHBevierWCJovanovicLDoyleFJ3rd. Prandial insulin dosing using run-to-run control: Application of clinical data and medical expertise to define a suitable performance metric. Diabetes Care.2007; 30 (5): 1131–6.
22.
García-SáezGAlonsoJMMoleroJRiglaMMartínez-SarrieguiILeivaAGómezEJHernandoEM. Mealtime blood glucose classifier based on fuzzy logic for DIABTel telemedicine system. Artif Intell Med.2009; 5651: 295–304.
23.
SalzsiederEAugsteinPVogtLKohnertKDHeinkePFreyseEAhmedA AzimMetwaliZSalmanIAttefO. Telemedicine-based KADIS combined with CGMS has high potential for improving outpatient diabetes care. J Diabetes Sci Technol.2007; 1 (4): 511–21.
HolbrookAThabaneLKeshavjeeKDolovichLBernsteinBChanDTroyanSFosterGGersteinHInvestigatorsCompeteII. Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial. CMAJ.2009; 181 (1–2): 37–44.
26.
Pérez-GandíaCFacchinettiASparacinoGCobelliCGómezEJRiglaMde LeivaAHernandoME. Artificial neural network algorithm for online glucose prediction from continuous glucose monitoring. Diabetes Technol Ther.2010; 12 (1): 81–8.
27.
BellazziRArcelloniMBensaGBlankenfeldHBruguésECarsonECobelliCCrampDD'AnnunzioGDe CataPDe LeivaADeutschTFratinoPGazzarusoCGarcìaAGergelyTGómezEHarveyFFerrariPHernandoEBoulosMKLarizzaCLudekkeHMaranANucciGPennatiCRamatSRoudsariARiglaMStefanelliM. Design, methods, and evaluation directions of a multi-access service for the management of diabetes mellitus patients. Diabetes Technol Ther.2003; 5 (4): 621–9.
